Ayurveda Medicine treats COVID-19 claims Patanjali CEO Balkrishna. Acharya Balkrishna claimed that Patanjali has found a cure to the COVID-19 Pandemic. He is the co-founder and Chief Executive Officer of Patanjali Ayurveda Limited. He has officially said that a medicine developed cures the patient within a span of 5-14 days. Moreover, as MNC pharmaceuticals around the world race to develop a vaccine. The Indian MNC Patanjali says that it has shown success among tested human patients in a trial!
Developing Ayurveda Medicine to COVID-19
After a clinical case study this Saturday. Hundreds of Covid-19 patients yielded “100% favorable results.” Furthermore he added. “We appointed a team of scientists after the COVID-19 outbreak. First, the simulation was done and compounds were identified. Which, can fight the virus and stop its spread in the body. Secondly, we then conducted a clinical case study on hundreds of positive patients.” Balkrishna said in Haridwar, according to ANI.
However, the vaccine also known has not been approved. The public eye has just been bought notice of the possible cure. Controlled clinical trials will happen in a week’s time. Announced results and evidence will be provided by the end of the week.
“After taking our medicine, Corona patients recovered in 5-14 days and tested negative. So, we can say the cure for Covid is possible through Ayurveda. We are performing controlled clinical trials only. In the next 4-5 days, evidence and data will be released by us,” he said.
Neither Balkrishna nor Ramdev have given details of the clinical trials. Although, Uttarakhand Government has approved a budget of 2.48 Crores Indian Rupees. This will use Patanjali Ayurveda products to boost citizen immunity.
Balkrishna’s claim Ayurveda Medicine treats COVID-19 came when India recorded its highest-ever spike. This was of 11,458 cases, according to the Union Ministry of Health and Family Welfare. Economists have further elaborated. In the perspective of latest events Patanjali has a potential to grow. If it succeeds India can expect to be hit by future trade deals. Being the first company in the world to successfully develop a vaccine to the Novel Corona Virus can be exceptional. Not only will India then supply it to world. But also India will strengthen and gain diplomatic immunity.